AB SCIENCE
Research AB SCIENCE (AB.PA) on Bullrun: market cap EUR 70.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAB.PA
- ExchangeXPAR
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 70.66M
- Financial periodFY2025
- RevenueEUR 1.17M
- Revenue growth9.5%
- Net income-EUR 1.56M
- Free cash flow-EUR 4.57M
- Gross margin83.3%
Valuation Snapshot
latest market cap is EUR 70.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 1.17M | -EUR 1.56M | -EUR 4.57M | 83.3% | -0.03 | EUR 10.18M | EUR 18.99M | -EUR 17.20M |
| FY2024 | EUR 1.07M | -EUR 7.83M | EUR 370.00K | 116.4% | -0.15 | EUR 7.99M | EUR 18.47M | -EUR 23.75M |
| FY2023 | EUR 970.00K | -EUR 11.99M | -EUR 17.22M | 60.5% | -0.24 | EUR 6.07M | EUR 19.10M | -EUR 21.01M |
| FY2022 | EUR 958.00K | -EUR 13.62M | -EUR 18.12M | 96.8% | -0.29 | EUR 7.27M | EUR 23.96M | -EUR 35.67M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-05 | EUR 70.66M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About AB SCIENCE
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.
Related stock research
Other Healthcare stocks
Boiron SA (BOI)
Euroapi SAS (EAPI)
Ipsen SA (IPN)
Vetoquinol (VETO)
AFFLUENT MEDICAL SAS EO 1 (0JZ)
Spineway SA (37S)
RENAU.UNSP.ARD 1/5 EO-20 (56S0)
Sartorius Stedim Biotech S.A. (56S1)
Nanobiotix (5NR)
INVENTIVA S.A.(PROM.)-01 (6IV)
Biophytis S.A. (6XB3)
VISIOMED GROUP EO 001 (7V91)
Frequently asked questions
What is AB SCIENCE's market cap?
AB SCIENCE's market capitalization is EUR 70.66M.
What does AB SCIENCE do?
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France.